The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may pose heightened risks for...

New research into widely used weight loss drugs, including Ozempic, reveals significant health risks. These drugs, initially developed for diabetes...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an increasingly popular option...

The impact of Ozempic and other GLP-1 receptor agonists like Wegovy, Mounjaro, and Zepbound on the alcohol and wine industry appears to be...

TUESDAY, Jan. 14, 2025 -- It takes a village to help a smoker quit. And a new study published recently in JAMA Internal Medicine shows that smokers...

GLP-1RA weight-loss drugs provide health benefits but also pose risks, including pancreatitis, kidney problems, and gastrointestinal issues.

FRIDAY, Jan. 17, 2025 -- There are racial and sex disparities in the discussion of and progression to metabolic and bariatric surgery (MBS) among...

TUESDAY, Jan. 21, 2025 -- Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such...

TUESDAY, Jan. 21, 2025 -- Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such...